New Providence, New Jersey-based Prosidyan, Inc. has announced a new study that provides evidence that its bioactive glass fiber-based bone graft substitute can achieve a 96.3% rate of spine fusion
Some spine surgeons say value-based care will grow with increased specialization of care delivery. Others argue value-based care poses conflicts for some patients and physicians.
An estimated 80% of the population will suffer from back pain during their lives. Scoliosis, a potentially painful back condition, will affect 3% of the population, or around nine million people